share_log

B. Riley Securities Maintains Buy on Journey Medical, Raises Price Target to $6

Benzinga ·  Jul 12, 2023 10:47

B. Riley Securities analyst Kalpit Patel maintains Journey Medical (NASDAQ:DERM) with a Buy and raises the price target from $3 to $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment